Equities

Runben Biotechnology Co Ltd

603193:SHH

Runben Biotechnology Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)20.35
  • Today's Change-0.14 / -0.68%
  • Shares traded2.81m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Runben Biotechnology Co Ltd is a China-based company mainly engaged in the production and sales of mosquito repellent products and daily necessities. The Company's main products can be divided into three sectors: mosquito repellent products, baby care products and essential oil products. The Company's principal products include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, skin care cream and others. The Company mainly provides products to consumers through Internet sales models such as online direct sales, online platform distribution, and online platform agency sales. The Company mainly conducts its businesses in the domestic market.

  • Revenue in CNY (TTM)1.05bn
  • Net income in CNY240.38m
  • Incorporated2013
  • Employees917.00
  • Location
    Runben Biotechnology Co Ltd#3 Xinzhuang 5th RoadEconomic Technology Development ZoneGUANGZHOU 510627ChinaCHN
  • Phone+86 2 038398399
  • Fax+86 2 038398366
  • Websitehttps://www.runben.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sino-Agri Leading Biosciences Co Ltd10.51bn228.04m5.37bn855.0023.533.59--0.51030.84830.848339.115.571.614.047.0212,297,100.003.854.3616.5416.427.296.952.392.290.7846--0.593546.61-10.5922.876.9114.26-13.4424.77
Hangzhou Haoyue Personal Care Co Ltd2.76bn444.94m7.20bn1.60k16.012.16--2.612.902.9018.0021.530.63586.7212.831,723,555.0010.2313.7813.3618.3427.3028.3316.0917.042.26--0.150624.02-1.6213.723.7218.8310.44--
Zhongnongfa Seed Industry Group Co Ltd6.39bn133.37m7.30bn1.18k54.773.83--1.140.12330.12335.911.761.437.5817.765,416,183.005.043.929.677.758.158.033.532.832.00--0.11610.0028.8214.43-44.7931.996.41--
Runben Biotechnology Co Ltd1.05bn240.38m8.23bn917.0034.254.21--7.860.59410.59412.594.84------1,143,007.00--------55.75--22.93--15.35--0.0019--20.66--41.23------
Data as of May 17 2024. Currency figures normalised to Runben Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

1.87%Per cent of shares held by top holders
HolderShares% Held
Penghua Fund Management Co., Ltd.as of 31 Dec 2023661.19k1.12%
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023142.17k0.24%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023109.63k0.19%
Rongtong Fund Management Co., Ltd.as of 31 Dec 202388.58k0.15%
Harvest Fund Management Co., Ltd.as of 31 Dec 202323.41k0.04%
Baoying Fund Management Co., Ltd.as of 31 Dec 202316.22k0.03%
HuaAn Fund Management Co., Ltd.as of 31 Dec 202316.19k0.03%
E Fund Management Co., Ltd.as of 31 Dec 202315.33k0.03%
China Merchants Fund Management Co., Ltd.as of 31 Dec 202314.83k0.03%
Fullgoal Fund Management Co., Ltd.as of 31 Dec 202312.21k0.02%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.